Krishna Institute of Medical Sciences has debuted at Rs 1008.90 on the BSE, up by 183.90 points or 22.29% from its issue price of Rs 825.
The scrip is currently trading at Rs 966.55, up by 141.55 points or 17.16% from its issue price. It has touched a high and low of Rs 1057.95 and Rs 950.00 respectively. So far 3.81 lakh shares were traded on the counter.
The offering which was opened for subscription between June 16, 2021 and June 18, 2021 was subscribed 3.86 times with retain individual investors subscribing 2.9 per cent, qualified institutional buyers subscribed 5.26 times and non-institutional investors subscribed 1.89 times. The issue price was fixed at Rs 825 per share i.e. at upper end of price band of Rs 815-825 apiece
Krishna Institute of Medical Sciences offers comprehensive range of healthcare services including oncology, cardiac sciences, neurosciences, gastric sciences, orthopaedics, renal sciences, organ transplantation, and mother & child care.
| Company Name | CMP |
|---|---|
| Apollo Hospital Ent. | 8080.95 |
| Max Healthcare Inst | 1037.80 |
| Narayana Hrudayalay | 1888.30 |
| Aster DM Healthcare | 739.85 |
| Global Health | 1239.10 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: